Reiner Fuellmich interviews Dr David Martin

We thought that you might be interested in the latest interview between attorney Reiner Fuellmich and Dr David Martin if you’ve not seen it yet.

Dr David Martin has been researching patents for decades. Having tried and failed to get people’s attention way back in the early 2000’s when the anthrax crisis hit, he’s been on the coronavirus trail since the pandemic was declared. In this interview with Reiner Fuellmich, he shares a revelatory summary of a large body of research spanning the last 20 years of following the patents trail that he and his team have painstakingly followed. To date his company M-CAM has reviewed over 4,000 patents related to SARS coronavirus, including a comprehensive review of the associated financing and companies involved.

Dr Wolfgang Wodarg, Attorney, Viviane Fischer and Prof Martin Schwab (legal advisor to the Corona Investigative Committee) join Mr Fuellmich and also contribute to the discussion.

Watch the interview

Click on the link to watch the full interview.

“…we took the reported gene sequence, which was reportedly isolated as a novel coronavirus — indicated as such by the ICTV (the International Committee on Taxonomy of Viruses of the World Health Organization). 

We took the actual genetic sequences that were reportedly “novel” and reviewed those against the patent records that were available as of the spring of 2020. And what we found, as you’ll see in this report, are over 120 patented pieces of evidence to suggest that the declaration of a novel coronavirus was actually entirely a fallacy.”
– Dr David Martin, M-CAM

“We need to increase public understanding of the need for medical countermeasures such as a pan coronavirus vaccine. A key driver is the media and the economics will follow the hype. We need to use that hype to our advantage to get to the real issues. Investors will respond if they see profit at the end of the process”

– Peter Dazsak, President EcoHealth Alliance